Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers. By Rebecca Robbins The Federal Trade Commission on Thursday issued what amounted to a ...
An examination of the Federal Circuit’s decision in In re Cellect, LLC, which held that patents awarded patent term adjustment (PTA) under 35 U.S.C. § 154(b) can be invalidated under the doctrine of ...
On August 13, the Federal Circuit issued a precedential ruling that reversed the District of Delaware's application of the Federal Circuit precedent in In re: Cellect to invalidate a claim in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback